Open access
Tissue and imaging biomarkers in the treatment of NSCLC
Summary The aim of this thesis was to investigate new biomarkers for immunotherapy in patients with non-small cell lung cancer (NSCLC). Although the use of immune checkpoint inhibitors in NSCLC has expanded considerably, the currently used biomarker PD-L1 expression is not sufficiently reliable. Not all patients with P...
A. Niemeijer
· 0 citations